Found 7 Diabetic Retinopathy trials
A listing of Diabetic Retinopathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Join a paid research study on health information on social media!The research study is being conducted to understand how health information and misinformation is shared and interacted with through Facebook wall posts, Twitter posts, and Google and YouTube searches. We’re interested in learning more about how people use information on …
This study seeks to find out whether an oral medication called Fenofibrate can slow or prevent worsening of diabetic retinopathy.
The purpose of this study is to (1) determine if circulating metabolites, including sphingolipids, are associated with severity of diabetic retinopathy (DR) in participants with diabetes mellitus type 2 and to (2) identify metabolic risk and protective factors that are associated with the development and progression of DR.
This study aims to find out if a new investigational drug, vilobelimab (also called IFX-1) is safe and effective in treating subjects 18 and older diagnosed Ulcerative Pyoderma Gangrenosum. Procedures include blood and urine tests, a physical examination, vital signs, body weight and height, an electrocardiogram (ECG), and full assessment …
Dr. Amit Bar-Or, MD, FRCPC from the University of Pennsylvania Department of Neurology is conducting a study to investigate how the structure and activity of gastrointestinal microbes (bacteria and fungi) found in the gut contribute to multiple sclerosis pathogenesis. You are being asked to participate in this study because either …
This is an early feasibility study looking at the safety, feasibility, and potential benefit of a medical device, called the NeuroPace RNS System, for people suffering from obesity, with uncontrolled eating habits.
The 5-year K01 Mentored Research Scientist proposal will employ brain, neurocognitive, and computational tools (e.g., machine learning) to understand the impact of opioid-use disorder (OUD) and common co-occurring issues on executive function and clinical outcomes.
